2-208146053-GCC-GC

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_005210.4(CRYGB):​c.10-38delG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.14 in 1,614,038 control chromosomes in the GnomAD database, including 16,328 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1835 hom., cov: 28)
Exomes 𝑓: 0.14 ( 14493 hom. )

Consequence

CRYGB
NM_005210.4 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts P:1B:4

Conservation

PhyloP100: -0.606
Variant links:
Genes affected
CRYGB (HGNC:2409): (crystallin gamma B) Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Gamma-crystallins are a homogeneous group of highly symmetrical, monomeric proteins typically lacking connecting peptides and terminal extensions. They are differentially regulated after early development. Four gamma-crystallin genes (gamma-A through gamma-D) and three pseudogenes (gamma-E, gamma-F, gamma-G) are tandemly organized in a genomic segment as a gene cluster. Whether due to aging or mutations in specific genes, gamma-crystallins have been involved in cataract formation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 2-208146053-GC-G is Benign according to our data. Variant chr2-208146053-GC-G is described in ClinVar as [Benign]. Clinvar id is 41988.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.192 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CRYGBNM_005210.4 linkuse as main transcriptc.10-38delG intron_variant ENST00000260988.5 NP_005201.2 P07316
CRYGBXM_017003402.2 linkuse as main transcriptc.10-38delG intron_variant XP_016858891.1
LOC100507443NR_038437.1 linkuse as main transcriptn.221+8879delC intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CRYGBENST00000260988.5 linkuse as main transcriptc.10-38delG intron_variant 1 NM_005210.4 ENSP00000260988.4 P07316

Frequencies

GnomAD3 genomes
AF:
0.151
AC:
22920
AN:
152062
Hom.:
1835
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.196
Gnomad AMI
AF:
0.265
Gnomad AMR
AF:
0.105
Gnomad ASJ
AF:
0.157
Gnomad EAS
AF:
0.0891
Gnomad SAS
AF:
0.155
Gnomad FIN
AF:
0.134
Gnomad MID
AF:
0.158
Gnomad NFE
AF:
0.139
Gnomad OTH
AF:
0.134
GnomAD3 exomes
AF:
0.136
AC:
34171
AN:
251308
Hom.:
2407
AF XY:
0.136
AC XY:
18524
AN XY:
135828
show subpopulations
Gnomad AFR exome
AF:
0.189
Gnomad AMR exome
AF:
0.0988
Gnomad ASJ exome
AF:
0.163
Gnomad EAS exome
AF:
0.0924
Gnomad SAS exome
AF:
0.155
Gnomad FIN exome
AF:
0.134
Gnomad NFE exome
AF:
0.140
Gnomad OTH exome
AF:
0.130
GnomAD4 exome
AF:
0.139
AC:
203327
AN:
1461858
Hom.:
14493
Cov.:
35
AF XY:
0.140
AC XY:
101603
AN XY:
727232
show subpopulations
Gnomad4 AFR exome
AF:
0.196
Gnomad4 AMR exome
AF:
0.101
Gnomad4 ASJ exome
AF:
0.161
Gnomad4 EAS exome
AF:
0.0863
Gnomad4 SAS exome
AF:
0.156
Gnomad4 FIN exome
AF:
0.136
Gnomad4 NFE exome
AF:
0.139
Gnomad4 OTH exome
AF:
0.142
GnomAD4 genome
AF:
0.151
AC:
22939
AN:
152180
Hom.:
1835
Cov.:
28
AF XY:
0.149
AC XY:
11092
AN XY:
74422
show subpopulations
Gnomad4 AFR
AF:
0.196
Gnomad4 AMR
AF:
0.105
Gnomad4 ASJ
AF:
0.157
Gnomad4 EAS
AF:
0.0883
Gnomad4 SAS
AF:
0.156
Gnomad4 FIN
AF:
0.134
Gnomad4 NFE
AF:
0.139
Gnomad4 OTH
AF:
0.133
Alfa
AF:
0.147
Hom.:
340
Bravo
AF:
0.148
Asia WGS
AF:
0.128
AC:
446
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cataract 39 multiple types Pathogenic:1Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpNov 29, 2022- -
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Pathogenic, no assertion criteria providedliterature onlyOMIMJan 01, 2012- -
Benign, no assertion criteria providedcurationReproductive Health Research and Development, BGI GenomicsJan 06, 2020NG_028158.1(NM_005210.3):c.10-38delG in the CRYGB gene has an allele frequency of 0.192 in African subpopulation in the gnomAD database, including 2819 homozygous. This variant was reported as g.67delG in a pedigree, which detected in congenital cataracts patients and a normal sibling (PMID: 23288985). This evidence suggests the variant to be classified as benign. ACMG/AMP criteria applied: BA1, BS2. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxOct 15, 2018This variant is associated with the following publications: (PMID: 23288985) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3214759; hg19: chr2-209010777; API